相关实验视频

Updated: Jul 22, 2026

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
06:33

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

11.4K

低成本的胸部儿童幻影用于剂量优化:构建和验证

A Mohammed Ali1, S Al-Murshedi2

  • 1Department of Radiological Techniques, College of Health and Medical Technology, Al-Zahraa University for Women, Karbala, Iraq; Department of medical physics, College of Applied Medical Sciences, University of Kerbala, 56001 Karbala, Iraq.

Radiologia
|July 29, 2023
PubMed
概括

为了胸部剂量优化研究,开发了一种使用软木,PVC和水的新型低成本成像幻影. 这种具有成本效益的幻影精确地复制了放射性特征,适合用于图像质量评估.

关键词:
无法获得的 无法获得的胸部幻影是一个幻影.剂量优化的优化胸部幻影 (Fantoma torácico) 是一个儿科图像的生成低成本的低成本的成本.优化剂量的优化儿科成像学 儿科成像学幻影验证验证 幻影验证幻影的验证 幻影的验证

更多相关视频

Fabrication and Characterization of Optical Tissue Phantoms Containing Macrostructure10:22

Fabrication and Characterization of Optical Tissue Phantoms Containing Macrostructure

Published on: February 12, 2018

10.7K
Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

4.1K

相关概念视频

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...